Central Nervous System Tumor
27
9
11
13
Key Insights
Highlights
Success Rate
93% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
3.7%
1 terminated out of 27 trials
92.9%
+6.4% vs benchmark
11%
3 trials in Phase 3/4
38%
5 of 13 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 13 completed trials
Clinical Trials (27)
Integrated Cancer Repository for Cancer Research
Expanded Access [11C] Methionine PET Imaging
Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors
ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors
A Study of Avutometinib for People With Solid Tumor Cancers
A Clinical Prediction Model for Surgical Site Infection After Central Nervous System Tumor Surgery
Tissue Collection for Drug Screening and Bioanalysis
Somatic Mosaicism in Twins Discordant for Childhood Cancer
Safety and Dose Finding Study of Neratinib in Children and Young Adults With Cancer That Has Returned or Not Responded to Treatment
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Brain Slice Explants to Predict Drug Response in Brain Tumors
Fluorescence Detection of Adult Primary Central Nervous System Tumors With Tozuleristide and the Canvas System
Biological Characterisation of High Risk CHildhood Cancer in Children, Adolescents and Young Adults (MICCHADO)
Longitudinal Study of Biomarkers
Medical Marijuana in the Pediatric Central Nervous System Tumor Population
Effect and Safety of Ocoxin Oral Solution on the Quality of Life of Paediatric Patients With Advanced Stage Solid Tumours
Mapping Draining Lymph Nodes in CNS Malignancies
Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy
Medical and Surgical Management of Patients With Brain Metastases
Dendritic Cell-based Immunotherapy for Advanced Solid Tumours of Children and Young Adults